SciVac Israel is a high growth biopharmaceutical company that develops, manufactures and markets recombinant human health care biotechnology derived products.SciVac Israel manufacture all stages of 3rd generation Hepatitis B vaccine from thawing of working cell bank through production, purification, formulation, filling, QC testing packaging and marketing. SciVac Israel has created its own research and development centre in order to focus on bacteria (E.coli) and mammalian cell (CHO cell) technology. At SciVac’s R&D centre continued advancement of its current molecules and other R&D activities are ongoing.Sci-B-Vac® http://israel21c.org/health/hepatitis-b-no-match-for-scigens-new-vaccine/?utm_source=Newsletter+4%2F24%2F2013&utm_campaign=April%2C+24%2C+2013&utm_medium=email